Remove 2017 Remove FDA Remove Fraud Remove Governance
article thumbnail

Federal Judge Refuses to Dismiss Florida Compounding Pharmacy’s FCA Suit

Pharmacy Law Blog

On December 4, 2017, a Florida federal judge refused to dismiss the federal government’s False Claims Act (FCA) suit against a compounding pharmacy. The federal judge refused the dismissal on the grounds that the government had sufficiently backed its allegations against both the company and its owner. December 4, 2017).

Fraud 52
article thumbnail

Health Provider News

Hall Render

Vincent reopens Westside Crossing Walk-In Care Indiana’s 2017 abortion law violates free speech, federal judge rules Ind. Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ ranks second nationwide in hospital patient safety, with 7 Central Va.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

health-tech startup MemoryWell pivots, eyes new funding to roll out software for insurers Department of Veterans Affairs health system kicks off multiyear Greater Washington expansion Georgetown to open Southeast D.C. Mississippi Dept.

article thumbnail

Hall Render’s Health Provider News – January 28, 2022

Hall Render

FDA halts use of antibody drugs that don’t work vs. omicron. FDA finalizes two guidances on including patient perspectives in medtech clinical trials. Federal officials arrest nursing home owner charged with more than $3M in Arkansas Medicaid fraud. Iowa surgical group pays $612K to resolve fraud allegations.

article thumbnail

Reading Tea Leaves: Judge Brown Jackson’s Decisions Relevant To Product Liability

Drug & Device Law

have dockets heavy on administrative cases and other cases involving the functioning of the federal government and light on product liability cases. 2017), and In re Air Crash Over the S. The briefing on motions to dismiss was complete in September 2017. Part of that may be that the D.D.C. Even the D.C. Medtronic, Inc. ,

FDA 59
article thumbnail

Terrible Decision Contravenes the Vaccine Act’s Purpose and Would Gut Its Protections

Drug & Device Law

The allegations in the complaint thus fell within the scope of the Vaccine Act, which governs all claims “for damages arising from a vaccine-related injury or death associated with the administration of a vaccine.” Kentucky Fried Chicken , 2017 WL 6416296, at *4 (S.D.N.Y. that they would not have received otherwise.” Olin Corp. ,

FDA 115
article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

2023) (federal government may unilaterally obtain dismissal of FCA claims, and calling the constitutionality of the FCA’s private enforcement mechanism into question) ( here ); Quishenberry v. 2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. The FDA’s five reviews of teratogenic risk all came to the same conclusion.

FDA 105